A Small-Molecule Antagonist of CXCR4 Inhibits Intracranial Growth of Primary Brain Tumors

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.2235846100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer

Journal of Cancer Therapy
2013English

Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth in Vivo

Cancer Research
Cancer ResearchOncology
2007English

Inhibition of the CXCL12/CXCR4 Chemokine Axis With AMD3100, a CXCR4 Small Molecule Inhibitor, Worsens Murine Hepatic Injury

Hepatology Research
HepatologyInfectious Diseases
2014English

EPI-X4, a Novel Endogenous Antagonist of CXCR4

Oncotarget
Oncology
2015English

Treatment and Prognosis of Primary Intracranial Germ Cell Tumors

Neurologia Medico-Chirurgica
SurgeryNeurology
1983English

A Small Molecule FAK Kinase Inhibitor, GSK2256098, Inhibits Growth and Survival of Pancreatic Ductal Adenocarcinoma Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Idalopirdine – A Small Molecule Antagonist of 5-Ht6 With Therapeutic Potential Against Obesity

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2015English

Oral Consumption of Pomegranate Fruit Extract Inhibits Growth and Progression of Primary Lung Tumors in Mice

Cancer Research
Cancer ResearchOncology
2007English

A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance

Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy